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Figure 8. Predicted binding poses for (A) ppFucCS1, (B) ppFucCS2, (C) ppFucCS3, (D)
IbSF and (E) heparin, bound to wild-type (left panel) and N501Y mutant (right panel) of
SARS-CoV2 S-protein RBD. (F) Average of top docking scores from five independent
docking runs. Error bars are represented as standard deviation. Docked glycan in wild-
type (pink) and in N501 mutant (green), and selected neighboring interacting residues
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Future Work
q Study the effect of the GAGs in various binding regions of RBD SGP using a variety of 
docking programs and force fields, to discern the most reliable approaches.
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Figure 7. Molecular modeling of marine glycans in their unbound and bound state with SARS-CoV-2 S-protein RBD. (A, B, C, D): 2D plots of the distribution of glycosidic 
torsion angles of the marine glycans in their unbound state, from 1 µs MD simulations. (A’, B’, C’, D’): 2D plots of the distribution of glycosidic torsion angles of the marine 
glycans in their bound state with S-protein RBD, from 200 ns MD simulations. 3D conformations of marine isolated glycans are shown in sticks. Bound glycan glycosidic 








































































































q MD simulations show that the dihedral angles of docked 





















q SPR shows that the glycans inhibit 
surface heparin interactions with RBD
q The best scored pose of the docked glycan at the 
RBD SGP investigated
q Similar key binding interactions with RBD were 
observed for the glycans in WT & N501Y
q Stronger inhibition was observed in the mutant 
S-protein
Results
q The outbreak of severe acute respiratory syndrome-
related coronavirus 2 (SARS-CoV-2) has created a 
global pandemic.
q The entry of SARS-CoV-2 inside the host cell is 
mediated by S-protein (SGP).
q Several glycosaminoglycans (GAGs) bind to SGP.
q New mutants such as N501Y in the SGP receptor 
binding domain (RBD) enable tighter binding to its 
receptor ACE2, leading to higher infection and 
transmission rates. 
q Here, we have studied the structural characteristics of 
novel fucosylated chondroitin sulfates (fCS) extracted 
from Pentacta pygmaea and Isostichopus badionotus.
q Computational and experimental studies have been 
conducted to investigate the anti-SARS-CoV-2 and 
binding properties of the extracted GAGs to wild-type 
(WT) and mutant RBD of SARS-CoV-2 SGP.
q The extracted GAGs bind stronger with 
the WT RBD than with the mutant
q SGP RBD model was built based on PDB ID: 6M0J[1].
q Molecular docking was performed using AutoDock Vina[2].
q All-atom molecular dynamics (MD) studies were done for 
structural characterization of the GAGs in their bound and 
unbound state, with GLYCAM06[3] force field, in explicit 
solvent, using the AMBER software package.
q Competitive surface plasmon resonance (SPR) inhibition 
analysis of the GAGs was performed against surface 
heparin.
